Research Report Screener Results

Report Screener | Stock Screener | Bond Screener | Fund Screener

Report Search Results As of 24-Nov-2009
New Screen

All Reports | Brokerage Reports | Independent Reports

All Reports (Showing 1 to 10 of 31)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
24-Nov-09 New Constructs, LLC N/A CLDX: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199 View Abstract
22-Nov-09 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: CELLDEX THERAPEUTICS INC 5 $25 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Industry Value Graph: AVGN , CLDX , CRIS , FACT , LJPC , PPHM , VION -- DRUGS 3 $4 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Value Graph: CELLDEX THERAPEU -- CLDX 1 $4 View Abstract
16-Nov-09 Argus Research Corporation David Coleman Vickers Weekly Insider, 11/16/09 52 $50 View Abstract
15-Nov-09 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: CELLDEX THERAPEUTICS INC 5 $25 View Abstract
13-Nov-09 Directors Deals Ltd. Company Snapshot Company Snapshot - Celldex Therapeutics Inc 1 $10 View Abstract
11-Nov-09 Zacks Investment Research Inc. N/A CELLDEX THERAPT (CLDX) Zacks Company Snapshot 1 $10 View Abstract
Next 20

Brokerage Reports (Showing 1 to 2 of 2)

Release
Date Contributor Author Title Pages Price StarMine Author Rating More Info

EPS Accuracy * Portfolio Return **
4-Nov-09 Brean Murray & Co., Inc. Jonathan M. Aschoff PhD CLDX: Reports 3Q09 Results – All Clinical Programs on Track 5 $10 View Abstract
29-Oct-09 Brean Murray & Co., Inc. Jonathan M. Aschoff PhD CLDX: Positive Phase 1 CDX-1307 Results at ISBTC Conference 4 $10 View Abstract

Independent Reports (Showing 1 to 10 of 29)

Release
Date Contributor Author Title Pages Price More Info
24-Nov-09 New Constructs, LLC N/A CLDX: Risk/Reward Rating: Full Report: Cash Truth Behind the Reported Earnings 19 $10 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotechnology & Genetics Industry Market Research and Competitive Analysis 2010 569 $299 View Abstract
23-Nov-09 Plunkett Research, Ltd. Jack W. Plunkett Biotech & Genetics Industry Trends, Statistics & Analysis 2010 (Summary) 71 $199 View Abstract
22-Nov-09 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: CELLDEX THERAPEUTICS INC 5 $25 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Industry Value Graph: AVGN , CLDX , CRIS , FACT , LJPC , PPHM , VION -- DRUGS 3 $4 View Abstract
20-Nov-09 Ford Investor Services, Inc. N/A Value Graph: CELLDEX THERAPEU -- CLDX 1 $4 View Abstract
16-Nov-09 Argus Research Corporation David Coleman Vickers Weekly Insider, 11/16/09 52 $50 View Abstract
15-Nov-09 TheStreet.com Ratings N/A TheStreet.com Ratings Stock Report For: CELLDEX THERAPEUTICS INC 5 $25 View Abstract
13-Nov-09 Directors Deals Ltd. Company Snapshot Company Snapshot - Celldex Therapeutics Inc 1 $10 View Abstract
11-Nov-09 Zacks Investment Research Inc. N/A CELLDEX THERAPT (CLDX) Zacks Company Snapshot 1 $10 View Abstract
Next 19

* EPS Accuracy is a measure of an analyst's ability to accurately estimate the EPS for a company.
** Portfolio Return is a measure of the performance of an analyst's recommendations relative to his peers.

Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon.